Evidence map›Paper›PMID 27453467›Full record

ArticleCell2016

Multiple Origins of Virus Persistence during Natural Control of HIV Infection.

Eli A Boritz, Samuel Darko, Luke Swaszek, Gideon Wolf, David Wells, Xiaolin Wu, Amy R Henry, Farida Laboune, Jianfei Hu, David Ambrozak and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 182 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. HIV controllers, lessons learnt from the lymphoid tissues.Current opinion in HIV and AIDS · 2026
    Review
  5. The HIV reservoir landscape in elite controllers.Current opinion in HIV and AIDS · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. CD8Nature · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 1 country.

Eli A BoritzHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Samuel DarkoHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Luke SwaszekHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Gideon WolfHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
David WellsLeidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Xiaolin WuLeidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Amy R HenryHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Farida LabouneHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Jianfei HuHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
David AmbrozakImmunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Marybeth S HughesThoracic and Gastrointestinal Oncology Branch, NCI, NIH, Bethesda, MD 20892, USA.
Rebecca HohDepartment of Medicine, University of California, San Francisco, San Francisco, CA 94110, USA.
Joseph P CasazzaImmunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Alexander VostalImmunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Daniel BunisHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Krystelle Nganou-MakamdopHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
James S LeeHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Stephen A MiguelesLaboratory of Immunoregulation, NIAID, NIH, Bethesda, MD 20892, USA.
Richard A KoupImmunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
Mark ConnorsLaboratory of Immunoregulation, NIAID, NIH, Bethesda, MD 20892, USA.
Susan MoirLaboratory of Immunoregulation, NIAID, NIH, Bethesda, MD 20892, USA.
Timothy SchackerProgram in HIV Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Frank MaldarelliHIV Dynamics and Replication Program, NCI, NIH, Frederick, MD 21702, USA.
Stephen H HughesHIV Dynamics and Replication Program, NCI, NIH, Frederick, MD 21702, USA.
Steven G DeeksDepartment of Medicine, University of California, San Francisco, San Francisco, CA 94110, USA.
Daniel C DouekHuman Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA. Electronic address: ddouek@mail.nih.gov.
National Institutes of Health · USNational Institute of Allergy and Infectious Diseases · USLeidos (United States) · USUniversity of California, San Francisco · USUniversity of Minnesota · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanismsU19AI096109 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHACKER, TIMOTHY W · 2011 to 2015
$29.5M
Role of B Lymphocytes In HIV Infection And PathogenesisZIAAI000825 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MOIR, SUSAN · 2009 to 2025
$24.5M
HIV/SIV Replication In VivoZIAAI005014 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KOUP, RICHARD A · 2009 to 2025
$22.7M
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNPZIAAI000855 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CONNORS, MARK · 2009 to 2025
$20.0M
IntegraseZIABC011426 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HUGHES, STEPHEN H · 2012 to 2022
$14.0M
The HIV ReservoirZIAAI005034 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DOUEK, DANIEL CESAR · 2009 to 2025
$7.5M
Preventing the Establishment of Enfuvirtide-resistance in the Latent ReservoirK24AI069994 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2007 to 2016
$1.5M
Intramural NIH HHS ZIA AI005034NIAID NIH HHS K24 AI069994NIAID NIH HHS P30 AI027763NIAID NIH HHS U19 AI096109
6 · The paper itself

Abstract

Targeted HIV cure strategies require definition of the mechanisms that maintain the virus. Here, we tracked HIV replication and the persistence of infected CD4 T cells in individuals with natural virologic control by sequencing viruses, T cell receptor genes, HIV integration sites, and cellular transcriptomes. Our results revealed three mechanisms of HIV persistence operating within distinct anatomic and functional compartments. In lymph node, we detected viruses with genetic and transcriptional attributes of active replication in both T follicular helper (TFH) cells and non-TFH memory cells. In blood, we detected inducible proviruses of archival origin among highly differentiated, clonally expanded cells. Linking the lymph node and blood was a small population of circulating cells harboring inducible proviruses of recent origin. Thus, HIV replication in lymphoid tissue, clonal expansion of infected cells, and recirculation of recently infected cells act together to maintain the virus in HIV controllers despite effective antiviral immunity.

Indexed as

BloodCD4-Positive T-LymphocytesChronic DiseaseDNA, ViralHIV-1HIV InfectionsHumansLeukocytes, MononuclearLymph NodesProvirusesSequence Analysis, DNAVirus Physiological PhenomenaVirus ReplicationDNA, Viral

Identifiers

PMID27453467
PMCPMC4983216
OpenAlexW2504810550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.